In prostate and endometrial cancers, SPOP functions as a tumor suppressor by destabilizing oncoproteins such as AR, ERG, Nanog and BRD2-4 15-19, with point mutations in its MATH domain, a region critical for enzyme-substrate interaction 20. This evidence concerns the gene SPOP and neoplasm.